Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer. | Front Immunol | 2022 | 36601109 | PubTator, text mining | PubMed |
| IL-15 induced bystander activation of CD8+ T cells may mediate endothelium injury through NKG2D in Hantaan virus infection. | Front Cell Infect Microbiol | 2022 | 36590594 | PubTator, text mining | PubMed |
| Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4+Foxp3+ Treg Induction. | J Inflamm Res | 2022 | 36578517 | PubTator, text mining | PubMed |
| Inflammatory-driven NK cell maturation and its impact on pathology. | Front Immunol | 2022 | 36569860 | PubTator, text mining | PubMed |
| Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy. | Front Pharmacol | 2022 | 36569326 | PubTator, text mining | PubMed |
| Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma. | Front Genet | 2022 | 36568383 | PubTator, text mining | PubMed |
| Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy. | J Transl Med | 2022 | 36564823 | PubTator, text mining | PubMed |
| Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies. | J Immunother Cancer | 2022 | 36564129 | PubTator, text mining | PubMed |
| Harnessing NK Cells to Control Metastasis. | Vaccines (Basel) | 2022 | 36560427 | PubTator, text mining | PubMed |
| Amino Acids Metabolism in Retinopathy: From Clinical and Basic Research Perspective. | Metabolites | 2022 | 36557282 | PubTator, text mining | PubMed |
| The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands. | Int J Mol Sci | 2022 | 36555547 | PubTator, text mining | PubMed |
| Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence. | Nat Commun | 2022 | 36522333 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance. | Int J Mol Sci | 2022 | 36499561 | PubTator, text mining | PubMed |
| Artificial Intelligence in Pediatric Cardiology: A Scoping Review. | J Clin Med | 2022 | 36498651 | PubTator, text mining | PubMed |
| Identification and Validation of RELN Mutation as a Response Indicator for Immune Checkpoint Inhibitor Therapy in Melanoma and Non-Small Cell Lung Cancer. | Cells | 2022 | 36497098 | PubTator, text mining | PubMed |
| Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations. | Front Immunol | 2022 | 36483545 | PubTator, text mining | PubMed |
| Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer. | Front Pharmacol | 2022 | 36467072 | PubTator, text mining | PubMed |
| Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry. | Signal Transduct Target Ther | 2022 | 36460660 | PubTator, text mining | PubMed |
| The prospect of genetically engineering natural killer cells for cancer immunotherapy. | Biol Open | 2022 | 36445164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=21